SVP and Chief Business Officer Michel Dahan sold $27K of Akebia Therapeutics, Inc.

Sold$27,457

$19.64Price

1,398Shares

−1%Stake

What AKBA did after the filing

Prices for AKBA after this filing aren't in yet.

Traded Mon, Oct 2. Filed Wed, Oct 4, 12:20 PM ET, during the session. Not investment advice.